Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2025-12-25 @ 9:27 PM
NCT ID: NCT03763656
Term: Sickle Cell Anemia with Crisis/Vaso-Occlusive Crisis (VOC)
Organ System: Blood and lymphatic system disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA (23.1)
Notes: 'SCA with crisis' interchangeable with 'Vaso-Occlusive crisis (VOC).' n=7 events were Grade 3 or above in n=4 participants and did not meet the protocol definition of SAEs; Remainder n=46 in n=14 participants were mild/moderate severity.
Study: NCT03763656
Study Brief: Pharmacokinetics of Oral Hydroxyurea Solution
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 53 18 32 View